These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7652930)

  • 21. Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands.
    Buller S; Zlotos DP; Mohr K; Ellis J
    Mol Pharmacol; 2002 Jan; 61(1):160-8. PubMed ID: 11752217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of positive cooperativity between strychnine-like allosteric modulators and N-methylscopolamine at muscarinic receptors.
    Jakubík J; Dolezal V
    J Mol Neurosci; 2006; 30(1-2):111-2. PubMed ID: 17192652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The allosteric site regulates the voltage sensitivity of muscarinic receptors.
    Hoppe A; Marti-Solano M; Drabek M; Bünemann M; Kolb P; Rinne A
    Cell Signal; 2018 Jan; 42():114-126. PubMed ID: 29056499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscarinic receptors and novel strategies for the treatment of age-related brain disorders.
    Ehlert FJ; Roeske WR; Yamamura HI
    Life Sci; 1994; 55(25-26):2135-45. PubMed ID: 7997072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor.
    Jakubík J; Tucek S; El-Fakahany EE
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1033-41. PubMed ID: 12023535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bitopic muscarinic agonists and antagonists and uses thereof: a patent evaluation of US20160136145A1.
    Holzgrabe U; Decker M
    Expert Opin Ther Pat; 2017 Feb; 27(2):121-125. PubMed ID: 27967250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allosteric regulation of muscarinic receptors.
    Birdsall NJ; Lazareno S; Matsui H
    Prog Brain Res; 1996; 109():147-51. PubMed ID: 9009701
    [No Abstract]   [Full Text] [Related]  

  • 28. Crystal structure of the M
    Vuckovic Z; Gentry PR; Berizzi AE; Hirata K; Varghese S; Thompson G; van der Westhuizen ET; Burger WAC; Rahmani R; Valant C; Langmead CJ; Lindsley CW; Baell JB; Tobin AB; Sexton PM; Christopoulos A; Thal DM
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):26001-26007. PubMed ID: 31772027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: studies with chimeric receptors.
    Ellis J; Seidenberg M
    Mol Pharmacol; 2000 Dec; 58(6):1451-60. PubMed ID: 11093785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors.
    Disingrini T; Muth M; Dallanoce C; Barocelli E; Bertoni S; Kellershohn K; Mohr K; De Amici M; Holzgrabe U
    J Med Chem; 2006 Jan; 49(1):366-72. PubMed ID: 16392821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of novel and functionally selective non-competitive muscarinic antagonists as chemical probes.
    Boulos JF; Jakubik J; Boulos JM; Randakova A; Momirov J
    Chem Biol Drug Des; 2018 Jan; 91(1):93-104. PubMed ID: 28646631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.
    Birdsall NJ; Farries T; Gharagozloo P; Kobayashi S; Lazareno S; Sugimoto M
    Mol Pharmacol; 1999 Apr; 55(4):778-86. PubMed ID: 10101037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisquaternary caracurine V derivatives as allosteric modulators of ligand binding to M2 acetylcholine receptors.
    Zlotos DP; Buller S; Tränkle C; Mohr K
    Bioorg Med Chem Lett; 2000 Nov; 10(22):2529-32. PubMed ID: 11086722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of signal transduction at M2 muscarinic receptor.
    Krejcí A; Michal P; Jakubík J; Rícný J; Dolezal V
    Physiol Res; 2004; 53 Suppl 1():S131-40. PubMed ID: 15119944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allosterism at muscarinic receptors: ligands and mechanisms.
    Birdsall NJ; Lazareno S
    Mini Rev Med Chem; 2005 Jun; 5(6):523-43. PubMed ID: 15974931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosteric binding sites on muscarinic acetylcholine receptors.
    Wess J
    Mol Pharmacol; 2005 Dec; 68(6):1506-9. PubMed ID: 16183853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of muscarinic acetylcholine receptors via their allosteric binding sites.
    Jakubík J; Bacáková L; Lisá V; el-Fakahany EE; Tucek S
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8705-9. PubMed ID: 8710935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
    Matsui H; Lazareno S; Birdsall NJ
    Mol Pharmacol; 1995 Jan; 47(1):88-98. PubMed ID: 7838137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective enhancement of antagonist ligand binding at muscarinic M2 receptors by heparin due to receptor uncoupling.
    Wang SZ; Edmundson R; Zhu SZ; el-Fakahany EE
    Eur J Pharmacol; 1996 Jan; 296(1):113-8. PubMed ID: 8720484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation and allosteric modulation of a muscarinic acetylcholine receptor.
    Kruse AC; Ring AM; Manglik A; Hu J; Hu K; Eitel K; Hübner H; Pardon E; Valant C; Sexton PM; Christopoulos A; Felder CC; Gmeiner P; Steyaert J; Weis WI; Garcia KC; Wess J; Kobilka BK
    Nature; 2013 Dec; 504(7478):101-6. PubMed ID: 24256733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.